Testing effectiveness (Phase 2)Looking for participantsNCT03603223
What this trial is testing
Pembrolizumab in Treating Participants With Leukoplakia
Who this might be right for
ErythroleukoplakiaLeukoplakiaVerrucous Oral Leukoplakia
Jonsson Comprehensive Cancer Center 26